Open Accessibility Menu


COVID-19 Update – May 2023

The Department of Health and Human Services (HHS) announced on February 10, 2023, the end of the coronavirus public health emergency (PHE) on May 11, 2023.


The bivalent vaccine is now the standard vaccine authorized for use against COVID-19 in the US. All monovalent COVID-19 vaccines have been discontinued.

FHCP is offering the Moderna bivalent vaccine at no cost to members. Click here to find a location.

Vaccination Recommendations

The Moderna bivalent vaccine is authorized for individuals 6 months of age and older.

  • Everyone ages 6 months through 5 years with no previous doses of COVID vaccine should receive 2 doses of the bivalent vaccine 1 month apart. The severely immunocompromised should receive a 3rd dose of bivalent vaccine 1 month after the 2nd dose*.
  • Everyone ages 6 years through 11 years should receive 1 dose of the bivalent vaccine. The severely immunocompromised should receive a 2nd dose of the bivalent vaccine 2 months after the 1st dose*.
  • Everyone ages 12 years through 64 years should receive 1 dose of the bivalent vaccine.
  • Everyone 65 years and older should receive a 2nd dose of bivalent vaccine 4 months after the 1st dose. The severely immunocompromised should receive a 3rd dose of the bivalent vaccine 2 months after the 2nd dose*.

* Immunocompromised refers to persons who have undergone solid organ, bone marrow or stem cell transplant, or who are diagnosed with conditions that are considered to have an equivalent level of immunocompromise such as undergoing cancer treatment or have AIDS.

Vaccine Cross-Over Information

People who received the Johnson & Johnson vaccine at least 2 months ago or the Pfizer vaccine at least 6 months ago may cross over and receive a Moderna booster.


  • If you are not feeling well and have symptoms that may include shortness of breath, fever, or cough, it is recommended that you take an at-home COVID-19 test.
  • Access to free over-the-counter COVID-19 tests has ended, however, at-home tests may be purchased at a local or online pharmacy.
  • If your symptoms are severe, please visit an FHCP Testing Location. In addition to testing, members will also be evaluated by a provider.

Visiting an FHCP Facility

Members who are not having symptoms of COVID-19 are encouraged to continue scheduled appointments with their providers for routine care. We request that members who aren’t feeling well reschedule routine appointments.

Telehealth Virtual Visits

FHCP offers virtual visits to our members via telehealth with your provider or Doctor on Demand.

  • Call your FHCP staff provider’s office to set up a telehealth visit.
  • Doctor on Demand: 24/7 access to board-certified providers
  • Telehealth visits with non-FHCP staff physicians require the standard office copay.

For questions please contact:

  • FHCP Member Services: 386-615-4022 | 1-877-615-4022
    TRS Relay 711 TTY: 1-800-955-8770
  • FHCP Medicare Member Services: 386-615-5051 | 1-833-866-6559
    TRS Relay 711 TTY: 1-800-955-8770

Doctor on Demand

You are leaving
This site is owned and maintained by Doctor on Demand.
Proceed to Doctor on Demand